Emergent BioSolutions (EBS) Other financing activities (2010 - 2026)
Emergent BioSolutions (EBS) reported Other financing activities of $8.7 million for Q2 2026, compared with $200,000 a year earlier and up 210.7% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Other financing activities (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Emergent BioSolutions' Other financing activities came in at $14.6 million, up 55.3% year-over-year; for FY2025, it was $3.8 million, down 74.0% from FY2024.
- Other financing activities has a five-year compound annual growth rate of -22.7% (FY2020 to FY2025).
- By year, Other financing activities came in at $14.6 million in FY2024 (+484.0%), $2.5 million in FY2023 (-57.6%), $5.9 million in FY2022 (-57.2%) and $13.8 million in FY2021 (unchanged).
- Year over year, Other financing activities gained in two of the last four quarters, with growth averaging 73.0%.
- The high point for year-over-year Other financing activities in five years was Q1 2026 (growth of 460.0%); the low point was Q3 2025 (a decline of 96.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.8 million (Q1 2026), $2.8 million (Q4 2025) and $300,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn |
| 10 | Emergent BioSolutions | 328.43 Mn | -422.47 Mn | 137.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.90 Mn |
| Mar 31, 2026 | -2.80 Mn |
| Dec 31, 2025 | -4.20 Mn |
| Sep 30, 2025 | -300,000.00 |
| Jun 30, 2025 | -200,000.00 |
| Mar 31, 2025 | -500,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Sep 30, 2024 | -9.00 Mn |
| Jun 30, 2024 | -6.10 Mn |
| Mar 31, 2024 | -400,000.00 |
| Dec 31, 2023 | -100,000.00 |
| Sep 30, 2023 | -100,000.00 |
| Jun 30, 2023 | -200,000.00 |
| Mar 31, 2023 | -2.10 Mn |
| Dec 31, 2022 | -200,000.00 |
| Sep 30, 2022 | -300,000.00 |
| Jun 30, 2022 | -400,000.00 |
| Mar 31, 2022 | -5.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | -1.90 Mn |
API Access
Emergent BioSolutions Other financing activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();